Benzinga | Jan 19, 2021 08:04AM EST

Thermo Fisher Scientific to Acquire Point-Of-Care Molecular Diagnostics Provider Mesa Biotech For ~$450M In Cash

WALTHAM, Mass., Jan. 19, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction.